Gritstone bio Inc
Change company Symbol lookup
Select an option...
GRTS Gritstone bio Inc
QTWO Q2 Holdings Inc
DNAB Social Capital Suvretta Holdings Corp II
UPST Upstart Holdings Inc
GILT Gilat Satellite Networks Ltd
LAIXY LAIX Inc
SPHD Invesco S&P 500® High Dividend Low Volatility ETF
OXBR Oxbridge Re Holdings Ltd
NVO Novo Nordisk A/S
JNJ Johnson & Johnson
Go

Health Care : Biotechnology | Small Cap Value
Company profile

Gritstone bio, Inc. is a biotechnology company. The Company discover, develop, manufacture and deliver next generation cancer and infectious disease immunotherapy candidates by vaccine vectors, self-amplifying mRNA (samRNA) and chimpanzee adenovirus (ChAd). Its two oncology programs in clinical-stage development are GRANITE, individualized neoantigen-based immunotherapy, and SLATE, an off-the-shelf shared neoantigen-based immunotherapy. The Company has an infectious disease pipeline, which includes two programs in clinical-stage development: CORAL, a second-generation COVID-19 vaccine program that may have pan-coronavirus potential to protect against future coronavirus pandemics, and an HIV therapeutic/cure vaccine candidate that are collaborating on with Gilead Sciences, Inc. The Company’s product candidates include GRT-C907 (ChAd)/R908 (samRNA), GRT- C909 (ChAd)/R910 (samRNA), GRT-C909 (ChAd)/R910 (samRNA), GRT-R914 (samRNA), GRT-R912 (samRNA) and GRT-R918 (samRNA).

Closing Price
$2.57
Day's Change
0.04 (1.58%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.72
Day's Low
2.55
Volume
(Average)
Volume:
511,650

10-day average volume:
561,584
511,650

Helbiz to Announce Q2 2022 Results on August 15, 2022

1:00 pm ET August 11, 2022 (BusinessWire) Print

Helbiz, Inc. (Nasdaq: HLBZ), a global leader in micro-mobility, today announced that it will report its second quarter 2022 results after the market closes on August 15, 2022. Prior to the webcast, Helbiz will issue a press release reporting these results along with additional materials at https://investors.helbiz.com/.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220811005639/en/

What: 2022 Q2 Results When: Monday, August 15, 2022 Time: 4:30 p.m. EDT Where: Live Dial-in Details: North America (toll-free): +1 (800) 715-9871 International: +1 (646) 307-1963 Conference ID: 4146974 Webcast Link Replay Available: https://investors.helbiz.com/

A replay will be available after the conclusion of the live event. Both the live webcast and replay will be available on the Investor Relations section of the Company's website at https://investors.helbiz.com/.

About Helbiz

Helbiz is a global leader in micro-mobility services. Launched in 2015 and headquartered in New York City, the company offers a diverse fleet of vehicles including e-scooters, e-bicycles, and e-mopeds all on one convenient, user-friendly platform with over 50 licenses in cities around the world. Helbiz utilizes a customized, proprietary fleet management technology, artificial intelligence, and environmental mapping to optimize operations and business sustainability. Helbiz is expanding its urban lifestyle products and services to include live streaming services, food delivery and more, all accessible within its mobile app. For additional information, please visit www.helbiz.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220811005639/en/

SOURCE: Helbiz, Inc.">

Helbiz 

For media inquiries: 
Matt Rosenberg
Head of Communications, NA
press@helbiz.com 
+1 (646) 726-2146

For investor inquiries: 
The Blueshirt Group
Gary Dvorchak, CFA
gary@blueshirtgroup.com 
+1 (323) 240-5796
comtex tracking

COMTEX_412087059/1006/2022-08-11T13:00:00

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.